Bronson Crouch Biography and Net Worth

Chairman & CEO of Instil Bio

Mr. Crouch is an entrepreneur and investor with over 15 years of experience in the biotechnology and pharmaceutical industry. Mr. Crouch is currently the Managing Partner of Curative Ventures, a private equity investment firm focused on biopharma opportunities. Key investments in the recent past include CoStim Pharmaceuticals, Inc., an immuno-oncology-focused biotech company (acquired by Novartis in 2014), TCR2 Therapeutics, Inc. (Nasdaq: TCRR), a cell therapy company, Peloton Therapeutics, Inc., an oncology biotech company focused on renal cell cancer (acquired by Merck in 2019 for $1.1 Billion cash upfront) and iTeos Therapeutics, Inc., (Nasdaq: ITOS) an immuno-oncology biotechnology company.

How old is Bronson Crouch?: Mr. Crouch is currently 51 years old. There are 1 older executives and no younger executives at Instil Bio. The oldest executive at Instil Bio is Dr. Sandeep Laumas M.D., CFO & Chief Business Officer, who is 55 years old. Learn More on Bronson Crouch's age.
How do I contact Bronson Crouch?: The corporate mailing address for Mr. Crouch and other Instil Bio executives is CONTINENTAL BUILDING 25 CHURCH STREET, HAMILTON D0, HM1Z. Instil Bio can also be reached via phone at 972-499-3350 and via email at [email protected]. Learn More on Bronson Crouch's contact information.
Has Bronson Crouch been buying or selling shares of Instil Bio?: Bronson Crouch has not been actively trading shares of Instil Bio during the last ninety days. Learn More on Bronson Crouch's trading history.
Who are Instil Bio's active insiders?: Instil Bio's insider roster includes Bronson Crouch (Chairman & CEO ), and Sandeep Laumas (CFO & Chief Bus. Officer ). Learn More on Instil Bio's active insiders.
Are insiders buying or selling shares of Instil Bio?: In the last twelve months, insiders at the sold shares 1 times. They sold a total of 30,000 shares worth more than $701,700.00. The most recent insider tranaction occured on September, 10th when CFO Sandeep Laumas sold 30,000 shares worth more than $701,700.00. Insiders at Instil Bio own 46.5% of the company. Learn More about insider trades at Instil Bio.
Information on this page was last updated on 9/10/2025.

Bronson Crouch Insider Trading History at Instil Bio

Bronson Crouch Buying and Selling Activity at Instil Bio

Instil Bio Company Overview

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.

Today's Range

Now: $11.25

$10.75

$11.29

50 Day Range

MA: $15.26

$10.78

$21.10

2 Week Range

Now: $11.25

$10.69

$42.79

Volume

60,342 shs

Average Volume

164,661 shs

Market Capitalization

$76.28 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.09